Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
Showing 2,421 - 2,440 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((greater decrease) OR (mean decrease)) ))', query time: 0.38s Refine Results
  1. 2421
    Fig 3 -

    Fig 3 - by Qingqing Hao (5464070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 2422
    Results of the LMM analysis for IOP change.

    Results of the LMM analysis for IOP change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
    Save to List
    Saved in:
  3. 2423
    Results of the LMM analysis for GMS change.

    Results of the LMM analysis for GMS change. by Sayaka Kimura-Uchida (22793666)

    Published 2025
    “…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …”
    Save to List
    Saved in:
  4. 2424
    <i>CTSZ</i> SNPs significantly associated with TB severity in Ugandan household contact study cohorts, sorted by ascending <i>p</i>-value.

    <i>CTSZ</i> SNPs significantly associated with TB severity in Ugandan household contact study cohorts, sorted by ascending <i>p</i>-value. by Rachel K. Meade (22216529)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2425
    Fig 5 -

    Fig 5 - by Varun Tiwari (9258130)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 2426
    Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration.

    Effects of compound 4f on neuroinflammation in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 2427
    Pharmacokinetics and pharmacodynamics of compound 4f in mice.

    Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 2428
    Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration.

    Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 2429
    Effects of compound 4f on the seizure-like response elicited by kainic acid (KA).

    Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 2430
    Size variation of δ<sup>15</sup>N in <i>Mytilus galloprovincialis.</i>

    Size variation of δ<sup>15</sup>N in <i>Mytilus galloprovincialis.</i> by Antonio Bode (1473376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2431
    The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice.

    The effects of cannabinoid receptor antagonists against neuroprotective effects of compound 4f in KA-treated mice. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 2432
    Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration.

    Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 2433
    The basic characteristics of the included studies.

    The basic characteristics of the included studies. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2434
    Common definitions and criteria for metabolic syndrome.

    Common definitions and criteria for metabolic syndrome. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2435
    Assessment of study bias in the included research.

    Assessment of study bias in the included research. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2436
    Summary of subgroup analysis results.

    Summary of subgroup analysis results. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2437
    Original study data.

    Original study data. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2438
    Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis.

    Results of the effect of dietary anthocyanins on health outcomes, including effect size and heterogeneity analysis. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2439
    Forest plot.

    Forest plot. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2440
    Risk of bias assessment for eligible randomized controlled trials.

    Risk of bias assessment for eligible randomized controlled trials. by Junyin Pan (20700411)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: